Bromide

Bromide

SCHEMBL7230528

Br.O=[N+]([O-])c1cccc(-c2ncccc2CO)c1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.48
PDE4D Q08499 10/20 0.60
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
PDE4A P27815 9/20 0.52
PDE4C Q08493 5/20 0.52
IDO1 P14902 1/20 0.51
PDE4B Q07343 3/20 0.48
BCHE P06276 1/20 0.48
TOP1 P11387 1/20 0.47
MAPT P10636 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
KDM4E B2RXH2 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7236603 0.99 PDE4D (0.61) PDE4DMEN1KMT2APDE4APDE4C
Bromide SCHEMBL7238592 0.83 PDE4D (0.63) PDE4DMEN1KMT2APDE4APDE4C
SCHEMBL9002865 0.79 PDE4D (0.61) PDE4DMEN1KMT2APDE4APDE4C
SCHEMBL2082945 0.79 PDE4D (0.51) PDE4DMEN1KMT2APDE4APDE4C
SCHEMBL7230945 0.78 PDE4D (0.64) PDE4DPDE4APDE4CIDO1PDE4B
SCHEMBL28145745 0.78 PDE4D (0.64) PDE4DPDE4APDE4CIDO1PDE4B
SCHEMBL27364256 0.78 PDE4D (0.64) PDE4DMEN1KMT2APDE4APDE4C
SCHEMBL28144687 0.78 PDE4D (0.64) PDE4DKMT2APDE4APDE4CIDO1
SCHEMBL7273341 0.78 PDE4D (0.60) PDE4DMEN1KMT2APDE4APDE4C
SCHEMBL10768030 0.78 PDE4D (0.60) PDE4DMEN1KMT2APDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521643-B1 Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-18 US disclosed
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed